Reduction and discontinuation of support payments for measures to combat COVID-19
First written in FY2024-Q2. 2 of 3 entries say "Worsened", first in FY2024. Latest entry: FY2025.
No other company in this theme has enough history to compare yet.
- FY2025WorsenedAnnual report
「In addition to higher expenses due to rising prices and labor costs, a decline in the number of patients and lower revenue following the end of subsidies for COVID-19 measures combined to put pressure on operations」
The end of infection-control subsidies described in the previous fiscal year continues to be cited in the current fiscal year as a factor behind lower revenue at medical institutions and deteriorating business performance. - FY2024WorsenedAnnual report
「The operating environment for medical facilities and other institutions became extremely challenging due to higher expenditures, including the cost of materials and utilities, caused by inflation, in addition to a decline in the number of patients and lower revenue following the end of subsidies for COVID-19 measures.」
The reduction and discontinuation of infection-control subsidies described in the second quarter has, for the full year, been specified as lower revenue at medical facilities and other institutions following the end of the subsidies. - FY2024-Q2First statedAnnual report
「The reduction and discontinuation of subsidies provided as part of the measures against COVID-19 were also major factors contributing to the deterioration in business performance.」
The reduction and discontinuation of subsidies provided to medical and nursing care institutions as infection-control measures are newly described specifically as factors contributing to the deterioration in business performance.